You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 019668


✉ Email this page to a colleague

« Back to Dashboard


NDA 019668 describes CARDURA, which is a drug marketed by Viatris and is included in two NDAs. It is available from three suppliers. Additional details are available on the CARDURA profile page.

The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Summary for 019668
Tradename:CARDURA
Applicant:Viatris
Ingredient:doxazosin mesylate
Patents:0
Pharmacology for NDA: 019668
Mechanism of ActionAdrenergic alpha-Antagonists
Medical Subject Heading (MeSH) Categories for 019668
Suppliers and Packaging for NDA: 019668
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARDURA doxazosin mesylate TABLET;ORAL 019668 NDA ROERIG 0049-2410 0049-2410-10 100 TABLET in 1 BOTTLE (0049-2410-10)
CARDURA doxazosin mesylate TABLET;ORAL 019668 NDA ROERIG 0049-2512 0049-2512-10 100 TABLET in 1 BOTTLE (0049-2512-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Nov 2, 1990TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 2MG BASE
Approval Date:Nov 2, 1990TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 4MG BASE
Approval Date:Nov 2, 1990TE:ABRLD:Yes

Expired US Patents for NDA 019668

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viatris CARDURA doxazosin mesylate TABLET;ORAL 019668-004 Nov 2, 1990 ⤷  Sign Up ⤷  Sign Up
Viatris CARDURA doxazosin mesylate TABLET;ORAL 019668-001 Nov 2, 1990 ⤷  Sign Up ⤷  Sign Up
Viatris CARDURA doxazosin mesylate TABLET;ORAL 019668-003 Nov 2, 1990 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.